4//SEC Filing
Tibira Therapeutics, Inc. 4
Accession 0001209191-15-039687
CIK 0001311596operating
Filed
May 5, 8:00 PM ET
Accepted
May 6, 9:28 PM ET
Size
6.1 KB
Accession
0001209191-15-039687
Insider Transaction Report
Form 4
Cooper Jeffrey H
Director
Transactions
- Award
Stock Options (right to buy)
2015-05-04+13,539→ 13,539 totalExercise: $8.13Exp: 2024-06-08→ Common Stock (13,539 underlying)
Footnotes (2)
- [F1]Reporting Person received such stock option in exchange for a stock option to purchase Tobira Therapeutics, Inc. ("Tobira") common stock in connection with the merger of Tobira into Issuer (the "Merger"). Pursuant to the terms of the Merger agreement each Tobira stock option assumed will be determined by multiplying the number of options by the exchange ratio of 1.43 and rounding down to the nearest whole number.
- [F2]25% of the option shares will vest and become exercisable on June 9, 2015, and the remaining shares will vest ratably over the next 36 months of continuous service beginning on July 9, 2015, subject to the terms of the Issuer's 2010 Stock Plan.
Documents
Issuer
Tibira Therapeutics, Inc.
CIK 0001311596
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311596
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 9:28 PM ET
- Size
- 6.1 KB